A phase I multiple dose,dose escalation study of cG250 monoclonal antibody in patients with advancedrenal cell carcinoma
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 肿瘤学
[关键词] phase I clinical trial;renal cell carcinoma;human CA9 protein;cG250;chimeric antibody [时效性]
